Given that NRG1 promotes neuroinflammation and that blocking NRG1 reduces neuroinflammation prevents neuronal loss in ALS, here we explored the effects of NRG1 and GlyB4 on early AD disease pathology in the 5XFAD animal model. The gene discussed is NRG1; the disease is amyotrophic lateral sclerosis.